Vicarious Surgical Inc(RBOT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 23 at 4:00 PM ET (Korea 10/24 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -9.04 | Insider Own | 41.33% | Shs Outstand | 5.3M | Perf Week | -5.88% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | -0.13% | Shs Float | 4.2M | Perf Month | -7.25% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 15.59% | Short Float | 9.18% | Perf Quarter | -26.15% |
| Income | -0.05B | P/S | - | EPS this Y | - | Inst Trans | -3.64% | Short Ratio | 2.72 | Perf Half Y | -67.12% |
| Sales | 0.00B | P/B | 0.81 | EPS next 5Y | - | ROA | -97.47% | Short Interest | 0.38M | Perf YTD | -11.52% |
| Book/sh | 2.36 | P/C | 1.02 | EPS past 3/5Y | 0.56% -634.04% | ROE | -148.93% | 52W High | -86.03% ($13.75) | Perf Year | -82.55% |
| Cash/sh | 1.88 | P/FCF | - | Sales past 3/5Y | - | ROIC | -209.2% | 52W Low | 12.28% ($1.71) | Perf 3Y | -97.52% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 15.03% | Gross Margin | - | Volatility(W/M) | 9.06% 10.31% | Perf 5Y | -99.37% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.22 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.75 | EPS Q/Q | 35.9% | Profit Margin | - | RSI (14) | 43.48 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.75 | Sales Q/Q | - | SMA20 | -2.56% ($1.97) | Beta | 1.55 | Target Price | $5 |
| Payout | - | Debt/Eq | 0.91 | Earnings | 2025/11/12 | SMA50 | -13.1% ($2.21) | Rel Volume | 0 | Prev Close | $1.92 |
| Employees | 123 | LT Debt/Eq | 0.82 | EPS/Sales Surpr. | 17.91% - | SMA200 | -64.59% ($5.42) | Avg Volume(3M) | 0.14M | Price | $1.92 |
| IPO | 2020/9/4 | Option/Short | No/Yes | Trades | 0 | Volume | - | Change | - |
💡 Virtual Incision Surgical (RBOT) is a medical technology company that researches and develops a high-performance intelligent surgical robotic platform that allows surgeons to perform sophisticated laparoscopic surgery through a single incision by wearing and controlling a virtual reality (VR) device.
Over the past 1 year, on the lower side
86% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
RBOT has a sound balance sheet but weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -99.4%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 15.6%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
UWM ProShares Ultra Russell 2000 2X Shares <0.01% It ranks #118 of 144 in the industry
Based on market cap of $14M.
ARAY#116 Accuray Inc $16M PER - 
BDMD#117 Baird Medical Investment Holdings Limited $14M PER - RBOT#118 Vicarious Surgical Inc $14M PER - 
PLSM#118 Pulsenmore Ltd $14M PER - 
IRIX#119 IRIDEX Corp $13M PER - 
FAQ
What kind of company is RBOT?
RBOT belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of RBOT?
The market cap of RBOT is approximately $14M, ranking 5,384 within its sector.
What is the 52-week high and low for RBOT?
RBOT has recorded a 52-week high of $13.75 and a low of $1.71.
